[1]
Boongird, S., Setthaudom, C., Kitpermkiat, R., Prasongtanakij, S., Srisala, S., Chuengsaman, P., Nongnuch, A., Nongnuch, A., Assanatham, M., Kiertiburanakul, S., Malathum, K., Phuphuakrat, A. and Bruminhent, J. 2022. Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients. Journal of the Nephrology Society of Thailand. 28, 4 (Dec. 2022), 69–70.